The 'greenness' of a mother's environment impacts the HMO composition in her breastmilk, according to a newly published study of Finnish breastfeeding women.
Plant-derived macronutrients are positively associated with higher pregnancy and postpartum human milk oligosaccharides (HMO) in breastmilk and could help mitigate the risk of allergies among infants, according to a study funded by Abbott Nutrition.
Individual human milk oligosaccharides (HMOs) may play critical roles in the maturation of gray matter in an infant brain, showing that inclusion of specific HMOs in infant formula could be beneficial, says a new study.
Chr. Hansen has received regulatory approval to supply a range of Human Milk Oligosaccharides (HMO) to new and existing global markets, following recent endorsements from Australia and New Zealand last year.
China’s food regulator is seeking public consultation on the use of the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) in infant formula as well as in foods for toddlers and young children.
A systematic review of dozens of studies has revealed that levels of the five most prevalent HMOs in breast milk vary widely, and infant formula development should accommodate this variability.
People with irritable bowel syndrome (IBS) may benefit from supplements of human milk oligosaccharides (HMOs), with a new study showing modulation of the gut microbiota, fecal and plasma metabolite profiles.
Over the last 20 years, the increase in exclusive breastfeeding and formula milk consumption, particularly in upper-middle-income countries, has led to product makers and ingredient suppliers revising plans in order to meet demand.
A recent analysis has found that the global infant formula ingredients market is expanding steadily with the rising middle class and the demand for high-quality infant formula gains traction.
Biomilq is a women-owned infant nutrition company that is producing cultured breastmilk in a lab. The company’s co-founder and CSO, Leila Strickland, PhD, sat down to discuss the inspiration behind this new kind of infant formula.
Belgian biotech company Inbiose, which develops human milk oligosaccharides (HMOs), has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) of four HMOs.
Supplementation with the human milk oligosaccharides (HMOs) HMOs 2'-fucosyllactose (2'FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study.
Levels of two specific human milk oligosaccharides (HMOs) are linked with measure of infant cognitive development, says a pilot study led by R&D Abbott Nutrition.
